We are live on ! Find out more
TP

Truvvo Partners Portfolio holdings

AUM $5.22M
1-Year Est. Return 13.74%
This Fund
S&P 500
This Quarter Est. Return
+1.67%
1 Year Est. Return
-13.74%
3 Year Est. Return
+21.12%
5 Year Est. Return
+59.28%
10 Year Est. Return
AUM
$132M
AUM Growth
-$17.5M
Cap. Flow
-$19.5M
Cap. Flow %
-14.81%
Top 10 Hldgs %
96.77%
Holding
27
New
Increased
5
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
VGSH icon
Vanguard Short-Term Treasury ETF
VGSH
+$456K
2
HD icon
Home Depot
HD
+$1.65K
3
MSFT icon
Microsoft
MSFT
+$696
4
AAPL icon
Apple
AAPL
+$513
5
MA icon
Mastercard
MA
+$349

Sector Composition

Rank Sector Weight
1 Financials 85.96%
2 Technology 2.65%
3 Consumer Discretionary 0.52%
4 Healthcare 0.45%
5 Energy 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDOC icon
26
Teladoc Health
TDOC
$1.66B
-74,321
Closed -$14.9M
NXTP
27
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
-12,602
Closed -$571K

Similar funds

Truvvo Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Truvvo Partners held 27 positions worth $132M, down 12% from $149M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Truvvo Partners withdrew a net $19.5M in Q1 2021, closing 4 positions and reducing 1 holding. Its most notable exit was Teladoc Health, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 86% of assets, up from 75% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Truvvo Partners added an estimated $456K to Vanguard Short-Term Treasury ETF.

  • Truvvo Partners added most to Vanguard Short-Term Treasury ETF in Q1 2021, an estimated $456K increase.
  • Truvvo Partners fully exited Teladoc Health in Q1 2021, selling an estimated $14.9M.
  • Truvvo Partners's ten largest holdings make up 97% of its $132M portfolio in Q1 2021.
  • Truvvo Partners opened 0 new positions and closed 4 in Q1 2021.
  • Truvvo Partners's portfolio value fell 12% quarter-over-quarter to $132M.

Based on Truvvo Partners's 13F filing for Q1 2021, filed 17 May 2021.